Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001045691 | SCV001209560 | benign | Tuberous sclerosis 1 | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002416367 | SCV002728237 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-07-15 | criteria provided, single submitter | clinical testing | The p.P684R variant (also known as c.2051C>G), located in coding exon 15 of the TSC1 gene, results from a C to G substitution at nucleotide position 2051. The proline at codon 684 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003462533 | SCV004204510 | uncertain significance | Isolated focal cortical dysplasia type II | 2021-09-20 | criteria provided, single submitter | clinical testing |